IP Verse

Vildagliptin Pharmaceutical Compositions - EP3512505

The patent EP3512505 was granted to Galenicum Health SL on Mar 15, 2023. The application was originally filed on Sep 18, 2017 under application number EP17768140A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3512505

GALENICUM HEALTH SL
Application Number
EP17768140A
Filing Date
Sep 18, 2017
Status
Granted And Under Opposition
Feb 10, 2023
Grant Date
Mar 15, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ELKINGTON AND FIFEDec 15, 2023ELKINGTON AND FIFEADMISSIBLE
KNPP PARTGMBBDec 13, 2023DR VOLGERADMISSIBLE
KNPP PARTGMBBDec 13, 2023VOLGERADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP2468361
DESCRIPTIONWO0034241
DESCRIPTIONWO2005067976
DESCRIPTIONWO2006021455
DESCRIPTIONWO2006078593
INTERNATIONAL-SEARCH-REPORTEP2468361
INTERNATIONAL-SEARCH-REPORTUS2011086096
INTERNATIONAL-SEARCH-REPORTWO2010036600
INTERNATIONAL-SEARCH-REPORTWO2014101986
INTERNATIONAL-SEARCH-REPORTWO2015097234
OPPOSITIONEP1715893
OPPOSITIONEP2468361
OPPOSITIONUS2011086096
OPPOSITIONWO2010036600
OPPOSITIONWO2011021322
OPPOSITIONWO2014101986
OPPOSITIONWO2015097234

Non-Patent Literature (NPL) Citations (16) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Ahmed Adel Sakr, Fars K. Alanazi , "Chapter 45- Oral Solid Dosage Forms ", Remington: The Science and Practice of Pharmacy 22nd Edition, Pharmaceutical Press , (20130101), pages 947 - 976, ISBN 978-0-85711-062-6, XP093002004-
OPPOSITION- Anonymous, "Drying", Pharmaceutical Process Engineering, Marcel Dekker, Inc., (20010101), pages 86 - 87, ISBN 978-0-8247-0298-4, XP093138961-
OPPOSITION- Anonymous, "Galvus 50 mg tablets", (20070926), pages 2 - 3,18, XP055592885-
OPPOSITION- Anonymous, "Low-Substituted Hydroxypropyl Cellulose NF / L-HPC - functional disintegrant", ShinEtsu, (20140901), ShinEtsu, XP093171564-
OPPOSITION- Aparna T Naga, Rao A Sambasiva, "Traditional and Emerging Disintegrants - A Review", International journal of pharmaceutical sciences review and research, Global Research Online Publishing House, IN, IN , (20130901), vol. 22, no. 1, ISSN 0976-044X, pages 205 - 212, XP093171543-
OPPOSITION- Carnet E. Peck, Josephine L. P. Soh, Kenneth R. Morris, "Chapter 9: Dry Granulation", Pharmaceutical Dosage Forms: Tablets 3rd Edition, volume 1: UNIT OPERATIONS AND MECHANICAL PROPERTIES, CRC Press, (20080101), pages 303 - 336, ISBN 978-1-4200-2028-1, XP055982201-
OPPOSITION- Jones, Brain E., "Capsules, Hard", Encyclopedia of Pharmaceutical Technology, Informa Healthcare USA, Inc, (20070101), vol. 1, pages 406 - 418, ISBN 0-8493-9396-5, XP009553379-
OPPOSITION- Mahato Ram I., Et Al., "Chapter 17: Tablets", Pharmaceutical Dosage Forms and Drug Delivery SECOND EDITION, CRC PRESS, (20120101), pages 313 - 335, ISBN 978-1-4398-4919-4, XP055982183-
OPPOSITION- Michael E. Aulton, "Drying", PHARMACEUTICS: THE SCIENCE OF DOSAGE FORM DESIGN, Second Edition, Elsevier , (20020101), pages 379 - 382, ISBN 0-443-05517-3, XP055306320-
OPPOSITION- Parikh D. M., Et Al., "Roller compaction technology", Handbook of Pharmaceutical Granulation Technology, Taylor & Francis , (20050101), pages 159 - 190, ISBN 978-0-8247-2647-8, XP055982211-
OPPOSITION- Rankell Albert, Herbert A Liberman, "Drying ", The Theory and Practice of Industrial Pharmacy second edition , Lea & Febiger , (19760101), pages 503 - 504, XP093138955-
OPPOSITION- Raymond C Rowe; Paul J Sheskey; Marian E Quinn, "Lactose, Anhydrous / Lactose, Inhalation / Lactose, Monohydrate", Raymond C Rowe; Paul J Sheskey; Marian E Quinn, Raymond C Rowe; Paul J Sheskey; Marian E Quinn (eds.), Handbook of Pharmaceutical Excipients, UK , Pharmaceutical Press , (20090101), pages 359 - 369, ISBN 978-0-85369-792-3, XP009553377-
OPPOSITION- Srikant Pimple, Akash Joshi; Mahesh Digge, Swami Astik, "Roller Compaction Design and Critical Parameters in Drug Formulation and Development: Review", International Journal of PharmTech Research, Shpinx Knowledge House, IN, IN , (20140101), vol. 7, no. 1, ISSN 0974-4304, pages 90 - 98, XP093171546-
OPPOSITION- Varma Karthik, "Excipients used in the Formulation of Tablets", Research and Reviews: Journal of Chemistry, (20160601), vol. 5, no. 2, ISSN 2319-9849, pages 143 - 154, XP093046003-
OPPOSITION- Michel Marre; Alfred Penfornis;, "GLP-1 receptor agonists today", DIABETES RESEARCH AND CLINICAL PRACTICE, AMSTERDAM, NL, NL , (20110106), vol. 93, no. 3, doi:10.1016/j.diabres.2011.01.004, ISSN 0168-8227, pages 317 - 327, XP028289489
OPPOSITION- Perez-Gandarillas L.; Mazor A.; Souriou D.; Lecoq O.; Michrafy A., "Compaction behaviour of dry granulated binary mixtures", Powder Technology, ELSEVIER, Basel (CH), Basel (CH) , (19000101), vol. 285, doi:10.1016/j.powtec.2015.05.003, ISSN 0032-5910, pages 62 - 67, XP029278453

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents